Clinical Trials Sponsored by National Cancer Institute, Slovakia

Total 22032 results

National Cancer Institute (NCI)

Completed

Informed Consent in Pediatric Cancer Trials

Leukemia | Osteosarcoma | Neuroblastoma | Brain Tumors | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

Invasive Pulmonary Aspergillosis | Immunocompromised Host | Invasive Pulmonary Fungal Infection | Invasive Pulmonary Zygomycosis

United States
National Cancer Institute (NCI)

Completed

Amplification of Merkel Cell Polyomavirus From Skin Swabs

Polyomavirus

United States
National Cancer Institute (NCI)

Completed

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Cryptococcosis

United States
National Cancer Institute (NCI)

Completed

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

SNX-5422 to Treat Solid Tumor Cancers and Lymphomas

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

Liver Neoplasms

United States
National Cancer Institute (NCI)

Withdrawn

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Sarcoma | Osteosarcoma | Brain Tumor | Neuroblastoma | Wilms Tumor

United States
National Cancer Institute (NCI)

Completed

Tabectedin to Treat Children and Adolescents With Cancer

Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

Solid Tumors | Lymphomas

United States
National Cancer Institute (NCI)

Completed

Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium

End Stage Renal Disease (ESRD)

United States
National Cancer Institute (NCI)

Completed

Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer

Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis

End Stage Renal Disease | ESRD

United States
National Cancer Institute (NCI)

Completed

PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

Prostate Cancer | Prostate Neoplasm

United States
National Cancer Institute (NCI)

Completed

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers

HIV Infections | Lung Cancer | Drug Addiction | AIDS | Tobacco Addiction

United States
National Cancer Institute (NCI)

Completed

CDDO to Treat Solid Tumors and Lymphomas

Lymphoma | Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica

HTLV-I

Jamaica
National Cancer Institute (NCI)

Completed

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Myelodysplastic Syndrome (MDS) | Non-Hodgkin's Lymphoma (NHL) | Leukemia, Acute Myelogenous (AML) | Leukemia, Acute Lymphocytic (ALL) | Leukemia, Chronic Myelogenous (CML)

United States
National Cancer Institute (NCI)

Completed

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

Hereditary Leiomyomatosis and Renal Cell Cancer | Cutaneous Leiomyomas

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors

Lung Cancer | Prostate Cancer | Bladder Cancer | Thymic Cancer

United States
National Cancer Institute (NCI)

Terminated

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Breast Cancer | Bladder Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Terminated

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Multiple Myeloma | Leukemia, Plasma Cell

United States
National Cancer Institute (NCI)

Completed

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

Colorectal Neoplasms | Colorectal Tumors | Colorectal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Glioma

United States
National Cancer Institute (NCI)

Completed

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Melanoma | Skin Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

United States
National Cancer Institute (NCI)

Terminated

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

Kidney Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Completed

Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...

Melanoma | Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Completed

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Thymic Carcinoma | Thymoma

United States
National Cancer Institute (NCI)

Completed

MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma

Colorectal Neoplasms

United States
National Cancer Institute (NCI)

Completed

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

Hamartoma Syndrome, Multiple | Cowden's Disease

United States
National Cancer Institute (NCI)

Terminated

Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab for Recurrent Malignant Glioma

Recurrent High-Grade Gliomas | Malignant Gliomas

United States
National Cancer Institute (NCI)

Completed

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Completed

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Melanoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer

Metastatic Melanoma | Metastatic Kidney Cancer

United States
National Cancer Institute (NCI)

Terminated

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

Kidney Neoplasms

United States
National Cancer Institute (NCI)

Completed

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma

B-Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors

Lung | Breast | Ovarian | Cervical | Renal

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer

Breast Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma

Unspecified Childhood Solid Tumor, Protocol Specific | Neoplasm of Uncertain Malignant Potential

United States

Clinical Trials Sponsored by National Cancer Institute, Slovakia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations